Imam Abubakr A, Mattoo Tej K, Kapur Gaurav, Bloom David A, Valentini Rudolph P
Division of Nephrology and Hypertension, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Pediatr Nephrol. 2005 Dec;20(12):1776-80. doi: 10.1007/s00467-005-2026-2. Epub 2005 Aug 25.
Calciphylaxis is a rare, but life-threatening complication of end-stage renal disease (ESRD) that has been reported mostly in adult patients. The exact etiology is unknown, but the disease is commonly associated with a high calcium-phosphorus product and elevated levels of parathyroid hormone (PTH). We herein review the published reports on calciphylaxis in ESRD patients less than 18 years old and report the case of a patient with severe calciphylaxis who presented with lower extremity pain, muscle tenderness and difficulty in walking. The serum PTH was low, and the calcium-phosphorus product was normal. The diagnosis of calciphylaxis was confirmed by a muscle biopsy. Treatment with low calcium peritoneal dialysate and substitution of calcium-based phosphorus binders with sevelamer (Renagel) was unsuccessful. The patient's clinical condition progressed to extensive soft tissue calcification and ulcerating skin lesions. Nine months after the onset of symptoms, the patient died of cardiopulmonary arrest.
钙化防御是终末期肾病(ESRD)一种罕见但危及生命的并发症,大多在成年患者中报道。确切病因尚不清楚,但该疾病通常与高钙磷乘积及甲状旁腺激素(PTH)水平升高有关。我们在此回顾已发表的关于18岁以下ESRD患者钙化防御的报告,并报告一例严重钙化防御患者的病例,该患者表现为下肢疼痛、肌肉压痛和行走困难。血清PTH较低,钙磷乘积正常。通过肌肉活检确诊为钙化防御。使用低钙腹膜透析液及用司维拉姆(Renagel)替代钙基磷结合剂的治疗未成功。患者的临床状况进展为广泛的软组织钙化和皮肤溃疡病变。症状出现9个月后,患者死于心肺骤停。